Document Detail


Biotech outsourcing strategies cmc--biologics stream. June 17, 2010, Copenhagen, Denmark.
MedLine Citation:
PMID:  20716956     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Now in its third year, the Biotech Outsourcing Strategies (BOS) meeting organized by Bio2Business took place at the Søhuset Conference Centre in Hørsholm, Copenhagen. The focus of this year's event was the demanding and challenging area of chemistry, manufacturing and controls (CMC), and the meeting provided ample opportunity for lively discussion of the key issues surrounding this area. New for the 2010 conference, a biologics-focused lecture stream ran in parallel to the established small molecule stream. Both streams boasted a distinguished panel of keynote speakers who discussed all aspects of CMC from early stage scale-up through late stage clinical development. In addition to the keynote speakers, selected contract research organizations (CROs) gave short presentations on the solutions that they could provide to some of the challenges facing CMC. The meeting attracted more than 150 delegates from leading drug development companies and CRO service providers, and greatly facilitated the forging of new working relationships through pre-arranged one-to-one meetings. Moreover, exhibitions from event sponsors and considerable scheduled networking time over lunch and evening reception further enhanced the highly productive and interactive nature of the meeting.
Authors:
Kate Hamer
Related Documents :
18665876 - Conceptualising spirituality and religion for healthcare.
16227666 - Ethics, evidence, and public policy.
20069936 - Ethical challenges of military social workers serving in a combat zone.
12853276 - Policy and organizational issues in agromedicine: a survey of 2001 naac meeting attendees.
14608766 - How to make staff meetings more enjoyable and productive.
5304436 - Distribution and ecology of bulinus truncatus in khuzestan, iran.
Publication Detail:
Type:  Congresses     Date:  2010-09-01
Journal Detail:
Title:  mAbs     Volume:  2     ISSN:  1942-0870     ISO Abbreviation:  MAbs     Publication Date:    2010 Sep-Oct
Date Detail:
Created Date:  2010-11-04     Completed Date:  2011-04-14     Revised Date:  2011-09-02    
Medline Journal Info:
Nlm Unique ID:  101479829     Medline TA:  MAbs     Country:  United States    
Other Details:
Languages:  eng     Pagination:  461-5     Citation Subset:  IM    
Affiliation:
School of Chemistry, University of Nottingham, University Park, Nottingham, UK. pcxkh2@nottingham.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Monoclonal / biosynthesis*,  therapeutic use
Drug Industry / methods,  trends
Humans
Outsourced Services
Technology, Pharmaceutical / economics,  methods*,  trends
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Allele-specific methylation in the human genome: implications for genetic studies of complex disease...
Next Document:  Targeting HER2: a report on the in vitro and in vivo pre-clinical data supporting trastuzumab as a r...